These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38237390)
21. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy. Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494 [TBL] [Abstract][Full Text] [Related]
22. Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy. Roy S; Khan S; Jairajpuri DS; Hussain A; Alajmi MF; Islam A; Luqman S; Parvez S; Hassan MI J Biomol Struct Dyn; 2022 Sep; 40(14):6350-6362. PubMed ID: 33565370 [TBL] [Abstract][Full Text] [Related]
23. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, Alam MS; Lee DU Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310 [TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors. Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123 [TBL] [Abstract][Full Text] [Related]
25. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors. Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors. El-Adl K; El-Helby AA; Sakr H; El-Hddad SSA Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000068. PubMed ID: 32510731 [TBL] [Abstract][Full Text] [Related]
27. New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity. Maghraby MT; Mazyad Almutairi T; Bräse S; Salem OIA; Youssif BGM; Sheha MM Molecules; 2023 Oct; 28(20):. PubMed ID: 37894571 [TBL] [Abstract][Full Text] [Related]
28. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFR Raghunath Khedkar N; Sindkhedkar M; Joseph A Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies. Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050 [TBL] [Abstract][Full Text] [Related]
30. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study. AboulWafa OM; Daabees HMG; Badawi WA Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112 [TBL] [Abstract][Full Text] [Related]
31. Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations. Rojas S; Parravicini O; Vettorazzi M; Tosso R; Garro A; Gutiérrez L; Andújar S; Enriz R Eur J Med Chem; 2020 Dec; 208():112792. PubMed ID: 32949964 [TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374 [TBL] [Abstract][Full Text] [Related]
35. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents. Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259 [TBL] [Abstract][Full Text] [Related]
36. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability. Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850 [TBL] [Abstract][Full Text] [Related]
37. Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques. Campos LE; Garibotto FM; Angelina E; Kos J; Tomašič T; Zidar N; Kikelj D; Gonec T; Marvanova P; Mokry P; Jampilek J; Alvarez SE; Enriz RD Bioorg Chem; 2019 Oct; 91():103125. PubMed ID: 31401373 [TBL] [Abstract][Full Text] [Related]